Delivery Order SPE2DB22D2206-SPE2DB26FDU33
- Not listed
- The Defense Logistics Agency awarded a competitive delivery order to AmerisourceBergen Drug Corp on October 21, 2025, for the supply of Qualipita 60 mg tablets (30-count units) with a ceiling value of $11,073.97 and an ultimate completion date of October 22, 2025. This firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $999.999 billion prime vendor agreement designated SPE2DX and...
- The Defense Logistics Agency awarded a $16,035.05 delivery order to AmerisourceBergen Drug Corp on August 13, 2025, for the supply of Qualipita 60 mg tablets (30-count packages). This competitively awarded, firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999.9 million through December 2026. The pharmaceutical will be supplied from the contractor's facility in...
- The Defense Logistics Agency awarded a delivery order valued at $10,507.55 to AmerisourceBergen Drug Corp for Qualipita 60 mg tablets (30-count) on May 22, 2025, with completion scheduled for May 23, 2025. This firm fixed-price delivery order, which carries no set-aside designation, represents a direct fulfillment of pharmaceutical supply needs for federal medical procurement. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, performed...
- The Defense Logistics Agency awarded a delivery order valued at $2,289.25 to AmerisourceBergen Drug Corp on August 25, 2025, for the supply of Qualipita 60 mg tablets (30-count units). This firm fixed-price contract, with an ultimate completion date of August 26, 2025, represents a competitive, non-set-aside award for pharmaceutical delivery to support federal medical procurement needs. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania....
- The Defense Logistics Agency awarded a $8,924.51 delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Qualipita 60 mg tablets (30-count units) under a firm fixed-price contract structure. This competitively awarded, non-set-aside delivery order is set to conclude by July 29, 2025, with performance at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on April 1, 2025, for the supply of Qualiptа 60 mg tablets (30-count units) under a firm fixed price contract with a ceiling value of $3,728.78 and an ultimate completion date of April 2, 2025. This non-competitive delivery order represents a single pharmaceutical supply transaction executed through the company's existing contract vehicle with DLA. The place of performance is located in Conshohocken,...
- The Defense Logistics Agency awarded a $26,473.25 delivery order to AmerisourceBergen Drug Corp for Qualipta 60 mg tablets (30-count units) on September 8, 2025, with an ultimate completion date of September 9, 2025. This firm fixed-price, competitively awarded contract carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 27, 2025, for the supply of Qualipта 60 mg tablets (30-count packaging) with a ceiling value of $4,044.33. This is a firm fixed price delivery order with no set-aside designation, indicating the contract was competitively awarded. The contract is set to be completed by October 28, 2025, and performance will be executed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania....
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Qualipita 60 mg tablets (30-count) under a firm fixed price contract. The order, valued at $13,271.90, was competitively awarded without set-aside provisions and carries an ultimate completion date of October 21, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order represents a child contract under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 10, 2025, for the supply of Qualipita 60 mg tablets (30-count) with a ceiling value of $6,073.01. This competitively awarded, firm fixed-price delivery order is not associated with any set-aside designation and requires completion by July 11, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- SPE2DB22D2206Indefinite Delivery Contract
- SPE2DB22D2206-SPE2DB26FDU33Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 27, 2025, for the supply of Qualipita 60 mg tablets in a 30-count configuration. This firm fixed-price delivery order, valued at $21,802.28, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical designated SPE2DX, which carries a $999,999,999.00 ceiling and extends through December 2026. The award was made without a set-aside designation through open competition, with performance scheduled for completion by October 28, 2025, and fulfillment occurring at AmerisourceBergen's corporate facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp serves as a critical pharmaceutical distributor for federal military and veteran healthcare systems through its extensive portfolio of delivery orders with the Defense Logistics Agency. The company's SPE2DX prime vendor contract functions as a comprehensive global pharmaceutical support vehicle enabling the supply of brand-name and generic medications, vaccines, and specialized medical commodities across multiple therapeutic domains to support military healthcare programs worldwide. This procurement activity reflects the Defense Logistics Agency's ongoing demand for pharmaceutical products to support the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $21.8k | 10/27/25 |